Search Results

You are looking at 21 - 30 of 1,037 items for :

Clear All
Gavin P Vinson School of Biological and Chemical Sciences, Queen Mary University of London, London E1 4NS, UK

Search for other papers by Gavin P Vinson in
Google Scholar
PubMed
Close
and
Caroline H Brennan School of Biological and Chemical Sciences, Queen Mary University of London, London E1 4NS, UK

Search for other papers by Caroline H Brennan in
Google Scholar
PubMed
Close

evidence for brain HPA function in addiction and shows that it is not autonomous, and its function is closely regulated by and linked to the systemic HPA. Corticotrophin releasing hormone Corticotrophin releasing hormone (CRH) is produced in various parts

Open access
Peter Bond Department of Internal Medicine, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
Department of Performance and Image-enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands

Search for other papers by Peter Bond in
Google Scholar
PubMed
Close
,
Tijs Verdegaal Department of Internal Medicine, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands

Search for other papers by Tijs Verdegaal in
Google Scholar
PubMed
Close
, and
Diederik L Smit Department of Internal Medicine, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
Department of Performance and Image-enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands

Search for other papers by Diederik L Smit in
Google Scholar
PubMed
Close

will describe how TTh is thought to induce erythropoiesis, discuss the evidence of TTh-induced erythrocytosis as a cause of thrombosis, and conclude on the potential beneficial or detrimental impact of providing therapeutic phlebotomy as a ‘treatment

Open access
Christian Trummer Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Christian Trummer in
Google Scholar
PubMed
Close
,
Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Stefan Pilz in
Google Scholar
PubMed
Close
,
Verena Schwetz Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Verena Schwetz in
Google Scholar
PubMed
Close
,
Barbara Obermayer-Pietsch Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Barbara Obermayer-Pietsch in
Google Scholar
PubMed
Close
, and
Elisabeth Lerchbaum Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria

Search for other papers by Elisabeth Lerchbaum in
Google Scholar
PubMed
Close

, evidence is accumulating that vitamin D deficiency is also a risk marker for insulin resistance ( 3 ), cardiovascular disease ( 4 ), infectious and autoimmune diseases ( 1 ), cancer ( 5 ), increased mortality ( 2 ) as well as decreased fertility ( 6

Open access
Giuseppe Lisco Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed
Close
,
Anna De Tullio Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Anna De Tullio in
Google Scholar
PubMed
Close
,
Olga Disoteo Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Search for other papers by Olga Disoteo in
Google Scholar
PubMed
Close
,
Giuseppina Piazzolla Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed
Close
,
Edoardo Guastamacchia Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed
Close
,
Carlo Sabbà Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Carlo Sabbà in
Google Scholar
PubMed
Close
,
Vincenzo De Geronimo Unit of Endocrinology, Policlinico Morgagni CCD, Catania, Italy

Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed
Close
,
Enrico Papini Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed
Close
, and
Vincenzo Triggiani Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed
Close

nonalcoholic fatty liver disease in randomized clinical trials ( 1 , 2 ) and real-life evidence ( 3 , 4 ). Since the approval, a rising interest has orbited around the GLP-1RAs, resulting in a high prescription rate of this class of medications in patients

Open access
Qi Che Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Qi Che in
Google Scholar
PubMed
Close
,
Xirong Xiao Department of Obstetrics, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

Search for other papers by Xirong Xiao in
Google Scholar
PubMed
Close
,
Jun Xu Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Jun Xu in
Google Scholar
PubMed
Close
,
Miao Liu Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Miao Liu in
Google Scholar
PubMed
Close
,
Yongning Lu Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yongning Lu in
Google Scholar
PubMed
Close
,
Suying Liu Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Suying Liu in
Google Scholar
PubMed
Close
, and
Xi Dong Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Xi Dong in
Google Scholar
PubMed
Close

invasive potential of endometrial cancer cells. We found that E2 could significantly promote endometrial cancer proliferation and invasion, which is consistent with the research results of other groups ( 16 , 17 ). Furthermore, our data provide evidence

Open access
Kelly Brewer Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, Connecticut, USA

Search for other papers by Kelly Brewer in
Google Scholar
PubMed
Close
,
Isabel Nip Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, Connecticut, USA

Search for other papers by Isabel Nip in
Google Scholar
PubMed
Close
,
Justin Bellizzi Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, Connecticut, USA

Search for other papers by Justin Bellizzi in
Google Scholar
PubMed
Close
,
Jessica Costa-Guda Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, Connecticut, USA
Center for Regenerative Medicine and Skeletal Development, Department of Reconstructive Sciences, University of Connecticut School of Dental Medicine, Farmington, Connecticut, USA

Search for other papers by Jessica Costa-Guda in
Google Scholar
PubMed
Close
, and
Andrew Arnold Center for Molecular Oncology, University of Connecticut School of Medicine, Farmington, Connecticut, USA
Division of Endocrinology and Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut, USA

Search for other papers by Andrew Arnold in
Google Scholar
PubMed
Close

. Some potential causes, such as stabilizing intragenic mutation ( 14 , 15 , 16 ) have not been substantiated by available evidence. Other possibilities, such as epigenetic upregulation via CCND1 promoter hypomethylation ( 17 , 18 ), have not yet

Open access
Alexis Sudlow Department of Upper GI Surgery, Southmead Hospital, Bristol, UK

Search for other papers by Alexis Sudlow in
Google Scholar
PubMed
Close
,
Carel W le Roux Department of Experimental Pathology, University College Dublin, Dublin, Ireland

Search for other papers by Carel W le Roux in
Google Scholar
PubMed
Close
, and
Dimitri J Pournaras Department of Upper GI Surgery, Southmead Hospital, Bristol, UK

Search for other papers by Dimitri J Pournaras in
Google Scholar
PubMed
Close

surgery than to continue living with the implications of obesity. Moreover, evidence from more than ten randomised controlled trials comparing bariatric surgery to medical care have consistently demonstrated more favourable results with regards to weight

Open access
Bogumila Urgatz Merck Healthcare KGaA, Darmstadt, Germany

Search for other papers by Bogumila Urgatz in
Google Scholar
PubMed
Close
and
Kris G Poppe University Hospital CHU Saint Pierre, Free University of Brussels, Brussels, Belgium

Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Close

.14 to 1.36) for TSH ≥10.00 μIU/mL) ( 25 ). While these studies added compelling evidence to our understanding of the danger of hypothyroidism per se during pregnancy, it should be noted that they did not differentiate between the effects of overt

Open access
Renea A Taylor Department of Physiology, Cancer Program and Obesity and Metabolic Disease Program, Biomedicine Discovery Institute, Monash University, Wellington Road, Victoria 3800, Australia

Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Close
,
Jennifer Lo Department of Physiology, Cancer Program and Obesity and Metabolic Disease Program, Biomedicine Discovery Institute, Monash University, Wellington Road, Victoria 3800, Australia

Search for other papers by Jennifer Lo in
Google Scholar
PubMed
Close
,
Natasha Ascui Department of Physiology, Cancer Program and Obesity and Metabolic Disease Program, Biomedicine Discovery Institute, Monash University, Wellington Road, Victoria 3800, Australia

Search for other papers by Natasha Ascui in
Google Scholar
PubMed
Close
, and
Matthew J Watt Department of Physiology, Cancer Program and Obesity and Metabolic Disease Program, Biomedicine Discovery Institute, Monash University, Wellington Road, Victoria 3800, Australia

Search for other papers by Matthew J Watt in
Google Scholar
PubMed
Close

between adulthood obesity and similar (10, 11, 12) or increased risk (8, 13) of developing prostate cancer, the stronger and more compelling epidemiological evidence shows that obese men have a significantly higher risk of being diagnosed with

Open access
Sophie Howarth Clinical and Translational Research Institute, Newcastle University, Newcastle upon Tyne, UK
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for other papers by Sophie Howarth in
Google Scholar
PubMed
Close
,
Luca Giovanelli Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for other papers by Luca Giovanelli in
Google Scholar
PubMed
Close
,
Catherine Napier Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for other papers by Catherine Napier in
Google Scholar
PubMed
Close
, and
Simon H Pearce Clinical and Translational Research Institute, Newcastle University, Newcastle upon Tyne, UK
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for other papers by Simon H Pearce in
Google Scholar
PubMed
Close

loss, hypoglycaemia and fatigue. Historically, the symptomatic phase was felt to be a point of no return for Addison’s patients, with a lifelong requirement for steroid replacement to avoid fatal adrenal crisis. However, a growing body of evidence

Open access